Legacy Pharmaceuticals International

Legacy Pharmaceuticals International is a customer-focused global manufacturer and seller of prescription, OTC, generic and cosmetic products. It adds significant value to clients' production needs through quality, reliability and competitive pricing. Legacy's manufacturing site has operated continuously in Europe since 1947. Legacy's main areas of business include contract manufacturing and the manufacture and sale of generic, branded generic, niche and specialty pharmaceuticals. Legacy manufactures and distributes finished pharmaceutical products for over 70 markets worldwide. Legacy Pharmaceuticals Switzerland is approved by Swissmedic and EMEA. It primarily serves European, Middle Eastern, CIS, and Asia-Pacific markets. Legacy also owns, manufactures and sells Solcoseryl injections for Japan. Legacy acquired the site and the management team from Valeant Pharmaceuticals International in 2007. The company has 150 employees among its operations in Switzerland and its administrative management office in Nevada.